Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 4/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21816850 | 0.87 | MAPT (0.58) | ALDH1A1CYP3A4TDP1GFERTSHR | |
| SCHEMBL14782754 | 0.87 | ALDH1A1 (0.58) | ALDH1A1CYP3A4TDP1GFERTSHR | |
| SCHEMBL6364651 | 0.85 | MAOB (0.40) | ALDH1A1CYP3A4TDP1TSHRMEN1 | |
| SCHEMBL14666066 | 0.82 | ALDH1A1 (0.46) | ALDH1A1CYP3A4TDP1GFERTSHR | |
| SCHEMBL13269343 | 0.79 | TAAR1 (0.52) | ALDH1A1TDP1TSHRLOXL2KMT2A | |
| SCHEMBL10284341 | 0.78 | HRH3 (0.52) | LOXL2MAPTCA12CA1CA2 | |
| SCHEMBL1528689 | 0.77 | GFER (0.59) | ALDH1A1CYP3A4TDP1GFERTSHR | |
| SCHEMBL3392101 | 0.77 | HRH3 (0.43) | TSHRMAOBCA12CA1CA2 | |
| SCHEMBL716339 | 0.76 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TDP1GFERTSHR | |
| SCHEMBL10436402 | 0.76 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TDP1GFERTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684202-A | 1, 4-Dihydropyridine derivative, and preparation method and application thereof | 中国石油大学(华东) | 2025-03-25 | — | — | CN | claimed |
| US-20240208987-A1 | EXATECAN-DERIVED ADC LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2024-06-27 | — | — | US | claimed |
| CN-117327244-A | Self-sensitization type radiochromic polyurethane elastomer and preparation method thereof | 四川大学 | 2024-01-02 | — | — | CN | claimed |
| CN-108169481-B | Test strip for detecting paeoniflorin and preparation method and application thereof | 河北省中药材质量检验检测研究中心有限公司 | 2023-07-07 | — | — | CN | claimed |
| US-20210170037-A1 | BRANCHED SUGAR ALCOHOL-BASED COMPOUNDS, AND COMPOSITIONS AND METHODS THEREOF | CELLMOSAIC INC (US) | 2021-06-10 | — | — | US | claimed |
| CN-112584871-A | Branched sugar alcohol-based compounds and compositions and methods thereof | 希默赛生物技术公司 | 2021-03-30 | — | — | CN | claimed |
| CN-108169481-A | A kind of test strips for detecting Paeoniflorin and its preparation method and application | 数字本草中医药检测有限公司 | 2018-06-15 | — | — | CN | claimed |
| CN-103232352-A | (R)-4-(2-(2-hydroxyl-2-phenylethylamino)-ethyl) tert-butyl phenylcarbamate | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-08-07 | — | — | CN | claimed |
| EP-0941120-A4 | BRANCHED PEPTIDE LINKERS | BRISTOL MYERS SQUIBB CO (US) | 2004-08-18 | — | — | EP | claimed |
| US-6759509-B1 | CONJUGATES CONTAINING A TARGETING LIGAND, SUCH AS AN ANTIBODY, A THERAPEUTICALLY ACTIVE DRUG AND A BRANCHED PEPTIDE LINKER | BRISTOL-MYERS SQUIBB COMPANY | 2004-07-06 | — | — | US | claimed |
| EP-0961619-A4 | HYDROLYZABLE PRODRUGS FOR DELIVERY OF ANTICANCER DRUGS TO METASTATIC CELLS | BRISTOL MYERS SQUIBB CO (US) | 2001-09-26 | — | — | EP | claimed |
| EP-0961619-A1 | HYDROLYZABLE PRODRUGS FOR DELIVERY OF ANTICANCER DRUGS TO METASTATIC CELLS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-12-08 | — | — | EP | claimed |
| EP-0941120-A1 | BRANCHED PEPTIDE LINKERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-09-15 | — | — | EP | claimed |
| WO-1998019705-A1 | BRANCHED PEPTIDE LINKERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-14 | — | — | WO | claimed |
| WO-1998013059-A1 | HYDROLYZABLE PRODRUGS FOR DELIVERY OF ANTICANCER DRUGS TO METASTATIC CELLS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-04-02 | — | — | WO | claimed |
| WO-2025072462-A1 | SULFONAMIDE DERIVATIVES AS CYCLIN-DEPENDENT KINASE 2 INHIBITORS | NIKANG THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| CN-119684202-A | 1, 4-Dihydropyridine derivative, and preparation method and application thereof | 中国石油大学(华东) | 2025-03-25 | — | — | CN | disclosed |
| US-5225532-A | SYMMETRICAL BIPEPTIDES CONTAINING A POLYALKYLENE GLYCOL RESIDUE, METHOD OF PREPARATION AND USE IN THE ASSAY OF PROTEASES | SERBIO (FR) | 1993-07-06 | — | — | US | disclosed |
| EP-0280610-B1 | DIPEPTIDES, PREPARATION PROCESS AND USE IN DOSING PROTEASES | SERBIO (FR) | 1992-10-21 | — | — | EP | disclosed |
| US-3957424-A | Enzyme-activated oxidative process for coloring hair | THE PROCTER & GAMBLE COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170037-A1 | BRANCHED SUGAR ALCOHOL-BASED COMPOUNDS, AND COMPOSITIONS AND METHODS THEREOF | SIGLEC7, CD44, SIGLEC9 | ALDH1A1 112/4885CYP3A4 2720/4885TDP1 4139/4885 |
| US-20240208987-A1 | EXATECAN-DERIVED ADC LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | ADCY3, ADCY8, ADCY7 | ALDH1A1 819/4885CYP3A4 4244/4885TDP1 1467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.